The Current Ratio as of September 2024 (TTM) for Quoin Pharmaceuticals, Ltd. (QNRX) is 3.35

According to Quoin Pharmaceuticals, Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 3.35. This represents a change of 1.38% compared to the average of 3.30 of the last 4 quarters.

Quoin Pharmaceuticals, Ltd. (QNRX) Historical Current Ratio (quarterly & annually)

How has QNRX Current Ratio performed in the past?

The mean historical Current Ratio of Quoin Pharmaceuticals, Ltd. over the last ten years is 4.16. The current 3.35 Current Ratio has changed 7.95% with respect to the historical average. Over the past ten years (40 quarters), QNRX's Current Ratio was at its highest in in the December 2019 quarter at 45.72. The Current Ratio was at its lowest in in the December 2016 quarter at 0.

Quoin Pharmaceuticals, Ltd. (QNRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Quoin Pharmaceuticals, Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Quoin Pharmaceuticals, Ltd. (QNRX) Average Current Ratio

How has QNRX Current Ratio performed in the past?

The current Current Ratio of Quoin Pharmaceuticals, Ltd. (QNRX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Quoin Pharmaceuticals, Ltd. (QNRX) Current Ratio vs. Peers

How is QNRX’s Current Ratio compared to its peers?

Quoin Pharmaceuticals, Ltd.’s Current Ratio is greater than Blue Water Vaccines, Inc. (0.54), greater than PaxMedica, Inc. Common Stock (2.40), greater than Revelation Biosciences, Inc. (1.10), greater than Hillstream BioPharma, Inc. (2.25), less than Virax Biolabs Group Limited (25.94), greater than NeuroBo Pharmaceuticals, Inc. (2.94), greater than Allarity Therapeutics, Inc. (2.01), greater than Kiromic BioPharma, Inc. (0.35), greater than Biodexa Pharmaceuticals Plc (1.26), less than Unicycive Therapeutics, Inc. (3.37), less than Cardio Diagnostics Holdings, Inc. (5.69),

Build a custom stock screener for Quoin Pharmaceuticals, Ltd. (QNRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Quoin Pharmaceuticals, Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Quoin Pharmaceuticals, Ltd. (QNRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Quoin Pharmaceuticals, Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.